Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Akela Pharma Inc. AKLPF

Healthcare Biotechnology
"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."


GREY:AKLPF - Post by User

Akela Pharma Inc. > Akela Pharma reports results
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Dukyon Aug 28, 2012 1:25pm
134 Views
Post# 20269905

RE: RE: RE: RE: Akela Pharma reports results

RE: RE: RE: RE: Akela Pharma reports results

Yes! Results did not seem bad (for last quarter). Exept, I noticed they did not have any info in cash flow section. Also what was private financing announcet in Feb this year? Looks positive, yet there is a delisting review by TSX. It is confusing to me, newbee.

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities